Resultats de la cerca - Stephen Lockhart

Refinar resultats
  1. 1
    Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

    Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome per Wendy Atkinson, Stephen Lockhart, Peter J. Whorwell, Brian Keevil, Lesley A. Houghton

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance

    Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance per James Hawley, Laura Owen, Stephen Lockhart, Phillip J. Monaghan, Annie Armston, Carrie Chadwick, Heather Wilshaw, Marcelo Freire, Leslie Perry, Brian Keevil

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Immunogenicity and Safety of a Combination Pneumococcal-Meningococcal Vaccine in Infants

    Immunogenicity and Safety of a Combination Pneumococcal-Meningococcal Vaccine in Infants per Jim Buttery, Anna Riddell, Jodie McVernon, Tracey Chantler, Laura A. Lane, Jane Bowen‐Morris, Linda Diggle, Rhonwen Morris, Anthony Harnden, Stephen Lockhart, Andrew J. Pollard, Keith Cartwright, E. Richard Moxon

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

    Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial per Michèle Tameris, Mark Hatherill, Bernard Landry, Thomas J. Scriba, Margaret Ann Snowden, Stephen Lockhart, Jacqueline E. Shea, J. Bruce McClain, Gregory Hussey, Willem A. Hanekom, Hassan Mahomed, Helen McShane

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

    Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media per Juhani Eskola, Terhi Kilpi, Arto A. Palmu, Jukka Jokinen, Mervi Eerola, Jaason Haapakoski, Elja Herva, Aino K. Takala, Helena Käyhty, P. Karma, Robert Kohberger, Stephen Lockhart, George R. Siber, P. Helena Mäkelä

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immuno... per A de Roux, Beate Schmöele-Thoma, George R. Siber, Jill Hackell, A. Kuhnke, N. Ahlers, Shirley Baker, Ahmad Razmpour, Emilio A. Emini, Philip Fernsten, William C. Gruber, Stephen Lockhart, Olaf Burkhardt, Tobias Welte, H. Lode

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

    Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial per Stephen J. Thomas, John L. Perez, Stephen Lockhart, Hariharan Subramanian, Nicholas Kitchin, Ruth Bailey, Katherine Liau, Eleni Lagkadinou, Özlem Türeci, Uğur Şahin, Xia Xu, Kenneth Koury, Samuel S. Dychter, Claire Lu, Teresa Gentile, William C. Gruber

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG

    Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG per Michèle Tameris, Helen McShane, J. Bruce McClain, Bernard Landry, Stephen Lockhart, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Jacqui Shea, Gregory Hussey, Linda van der Merwe, Marwou de Kock, Thomas J. Scriba, Robert Walker, Willem A. Hanekom, Mark Hatherill, Hassan Mahomed

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    CLOVER: A Phase 3 Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of <i>Clostridioides difficile</i> Infection

    CLOVER: A Phase 3 Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of <i>Clostridioides diffi... per Curtis J. Donskey, Erik R. Dubberke, Nicola P. Klein, Elizabeth Liles, Katarzyna Szymkowiak, Mark H. Wilcox, Jody Lawrence, Salim Bouguermouh, Haiying Zhang, Kenneth Koury, Ruth Bailey, Helen Smith, Stephen Lockhart, Erik Lamberth, Warren V. Kalina, Michael W. Pride, Chris Webber, Annaliesa S. Anderson, Kathrin U. Jansen, William C. Gruber, Nicholas Kitchin

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3

    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 per Ann R. Falsey, Robert W. Frenck, Edward E. Walsh, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Ruth Bailey, Kena A. Swanson, Xia Xu, Kenneth Koury, Warren V. Kalina, David Cooper, Jing Zou, Xuping Xie, Hongjie Xia, Özlem Türeci, Eleni Lagkadinou, Kristin Tompkins, Pei‐Yong Shi, Kathrin U. Jansen, Uğur Şahin, Philip R. Dormitzer, William C. Gruber

    Publicat 2021
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  11. 11
    Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

    Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report per Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Vanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren V. Kalina, David Cooper, Camila R. Fontes-Garfias, Pei‐Yong Shi, Özlem Türeci, Kristin Tompkins, Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen

    Publicat 2020
    Obtenir text complet
    Pré-impressão
    Afegir a favorits
    Guardat en:
  12. 12
    Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

    Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults per Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Vanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren V. Kalina, David Cooper, Camila R. Fontes-Garfias, Pei‐Yong Shi, Özlem Türeci, Kristin Tompkins, Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

    RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study per Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Mark J. Mulligan, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren V. Kalina, David Cooper, Camila R. Fontes-Garfias, Pei‐Yong Shi, Özlem Türeci, Kristin Tompkins, Kirsten E. Lyke, Vanessa Raabe, Philip R. Dormitzer, Kathrin U. Jansen, Uğur Şahin, William C. Gruber

    Publicat 2020
    Obtenir text complet
    Pré-impressão
    Afegir a favorits
    Guardat en:
  14. 14
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates per Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Mark J. Mulligan, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren V. Kalina, David Cooper, Camila R. Fontes-Garfias, Pei‐Yong Shi, Özlem Türeci, Kristin Tompkins, Kirsten E. Lyke, Vanessa Raabe, Philip R. Dormitzer, Kathrin U. Jansen, Uğur Şahin, William C. Gruber

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents per Robert W. Frenck, Nicola P. Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L. Perez, Emmanuel B. Walter, Shelly Senders, Ruth Bailey, Kena A. Swanson, Hua Ma, Xia Xu, Kenneth Koury, Warren V. Kalina, David Cooper, Timothy W Jennings, Donald M. Brandon, Stephen J. Thomas, Özlem Türeci, Dina B Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, Kathrin U. Jansen, William C. Gruber

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

    Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years per Patricia L. Winokur, Juleen Gayed, David Fitz-Patrick, Stephen J. Thomas, Oyeniyi Diya, Stephen Lockhart, Xia Xu, Ying Zhang, Vishva Bangad, Howard I. Schwartz, Douglas Denham, Jose F Cardona, Lisa Usdan, John Ginis, Federico Mensa, Jing Zou, Xuping Xie, Pei‐Yong Shi, Claire Lu, Sandra Buitrago, Ingrid L. Scully, David Cooper, Kenneth Koury, Kathrin U. Jansen, Özlem Türeci, Uğur Şahin, Kena A. Swanson, William C. Gruber, Nicholas Kitchin

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine per Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Edson Duarte Moreira, Cristiano A. F. Zerbini, Ruth Bailey, Kena A. Swanson, Satrajit Roychoudhury, Kenneth Koury, Ping Li, Warren V. Kalina, David Cooper, Robert W. Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Dina B Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, Kathrin U. Jansen, William C. Gruber

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

    Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine per Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cristiano A. F. Zerbini, Ruth Bailey, Kena A. Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V. Kalina, David Cooper, Robert W. Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen

    Publicat 2021
    Obtenir text complet
    Pré-impressão
    Afegir a favorits
    Guardat en:
  19. 19
    Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

    Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine per Edson Duarte Moreira, Nicholas Kitchin, Xia Xu, Samuel S. Dychter, Stephen Lockhart, Alejandra Gurtman, John L. Perez, Cristiano A. F. Zerbini, Michael Dever, Timothy W Jennings, Donald M. Brandon, Kevin D Cannon, Michael Koren, Douglas Denham, Mezgebe Berhe, David Fitz-Patrick, Laura L Hammitt, Nicola P. Klein, Haylene Nell, Georgina Keep, Xingbin Wang, Kenneth Koury, Kena A. Swanson, David Cooper, Claire Lu, Özlem Türeci, Eleni Lagkadinou, Dina B Tresnan, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months per Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cristiano A. F. Zerbini, Ruth Bailey, Kena A. Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V. Kalina, David Cooper, Robert W. Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: